These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11784512)

  • 21. Short-term side effects during H. pylori eradication therapy.
    Dumonceau JM
    Acta Gastroenterol Belg; 1998; 61(3):348-9. PubMed ID: 9795470
    [No Abstract]   [Full Text] [Related]  

  • 22. CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.
    Yang JC; Lin CJ
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):29-41. PubMed ID: 19968574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Helicobacter pylori infection.
    Fuccio L; Laterza L; Zagari RM; Cennamo V; Grilli D; Bazzoli F
    BMJ; 2008 Sep; 337():a1454. PubMed ID: 18794181
    [No Abstract]   [Full Text] [Related]  

  • 24. Drugs for Helicobacter pylori infection.
    Med Lett Drugs Ther; 2017 Jul; 59(1525):113-117. PubMed ID: 28699931
    [No Abstract]   [Full Text] [Related]  

  • 25. Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
    Ye CL; Liao GP; He S; Pan YN; Kang YB; Zhang ZY
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):443-55. PubMed ID: 24677603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical significance of Helicobacter pylori infection].
    Maev IV; Samsonov AA; Andreev DN; Grechushnikov VB; Korovina TI
    Klin Med (Mosk); 2013; 91(8):4-12. PubMed ID: 24437177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of Helicobacter pylori infection.
    Hunt RH
    Am J Med; 1996 May; 100(5A):42S-50S; discussion 50S-51S. PubMed ID: 8644782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Helicobacter pylori infection: is less more?
    Howden CW
    J Clin Gastroenterol; 2000 Sep; 31(2):105-6. PubMed ID: 10993423
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for
    Niikura R; Hayakawa Y; Hirata Y; Yamada A; Fujishiro M; Koike K
    Gut; 2018 Oct; 67(10):1908-1910. PubMed ID: 29273641
    [No Abstract]   [Full Text] [Related]  

  • 31. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: third-line rescue therapy with levofloxacin after failure of two treatments to eradicate Helicobacter pylori infection.
    Gisbert JP;
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1484-5; author reply 1486. PubMed ID: 22582841
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of proton pump inhibitor-based triple therapy with losec and the generic drug, Omepradex, for efficacy of Helicobacter pylori eradication.
    Niv Y
    Dig Dis Sci; 2005 Apr; 50(4):623-5. PubMed ID: 15844691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemistry as confirmatory test for current Helicobacter pylori infection in patients treated with proton pump inhibitors.
    Negovan A; Iancu M; Mocan S; Banescu C
    Eur J Intern Med; 2018 Apr; 50():e31-e32. PubMed ID: 29203056
    [No Abstract]   [Full Text] [Related]  

  • 35. Helicobacter pylori therapy in children: a focus on proton pump inhibitors.
    Chiesa C; Anania C; Pacifico L; Olivero G; Osborn JF
    Chemotherapy; 2011; 57(1):85-93. PubMed ID: 21346353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of proton pump inhibitors in the treatment of Holicobacter pylori-associated ulcers].
    Huang J; Lu X; Hunt RH
    Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):488-91. PubMed ID: 10436949
    [No Abstract]   [Full Text] [Related]  

  • 37. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.
    Hsu PI; Tsai FW; Kao SS; Hsu WH; Cheng JS; Peng NJ; Tsai KW; Hu HM; Wang YK; Chuah SK; Chen A; Wu DC
    Am J Gastroenterol; 2017 Sep; 112(9):1374-1381. PubMed ID: 28719592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendations for the management of Helicobacter pylori infection according to Maastricht 3 guidelines].
    Delchier JC
    Gastroenterol Clin Biol; 2006 Dec; 30(12):1361-4. PubMed ID: 17211333
    [No Abstract]   [Full Text] [Related]  

  • 39. The search for optimal Helicobacter pylori eradication regimen: a mid 1997 update.
    Deltenre M; De Bruyne L; Ntounda R; De Koster E; Lamy V
    Acta Gastroenterol Belg; 1998; 61(3):344-7. PubMed ID: 9795469
    [No Abstract]   [Full Text] [Related]  

  • 40. Helicobacter pylori and proton pump inhibitor therapy: One diagnostic method is enough?
    Ribaldone DG; Saracco GM; Pellicano R
    Eur J Intern Med; 2018 Apr; 50():e29-e30. PubMed ID: 29113707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.